The interleukin-7 (IL-7) signaling pathway plays essential roles in modeling the extracellular matrix and the development and homeostasis of B and T cells. Aberrant IL-7 signaling has been implicated in severe combined immunodeficiency, autoimmune conditions, and cancers. The IL-7 signal is triggered when soluble IL-7 interacts with two cell surface cytokine receptors, interleukin-7 receptor (IL-7R) and the common gamma- chain. In the previous funding period, we determined the structural, energetic, and cell biological features of the interaction of IL-7 with IL-7R. In this funding period, we will dissect the moleculr mechanisms of the interactions of IL-7 with glycosaminoglycans (e.g. heparin/heparin sulfate) and the common gamma-chain receptor with IL-7 and IL-7R. Preliminary studies of these interactions reveal the formation of unexpected non- activating complexes, either unique to IL-7 signaling or unidentified for the other common gamma-chain family members. Specifically, glycosaminoglycan binding induces dimer formation of IL-7, and common gamma- chain receptor can bind to IL-7 independent of IL-7R and to IL-7R independent of IL-7. Further studies will include three-dimensional x-ray crystallographic structures of the non-activating IL-7/GAG, IL-7/common gamma-chain, IL-7R/common gamma-chain complexes, as well as the activating IL-7/IL-7R/common gamma- chain ternary complex. The binding determinants of these epitopes also will be determined using site-directed scanning mutagenesis and various biophysical methods, including isothermal titration calorimetry and surface plasmon resonance. The structural and biophysical studies of non-activating and activating complexes ultimately will be used to develop models that explain normal and aberrant IL-7 signaling mechanisms and generate novel protein reagents and therapeutics that treat the numerous diseases associated with impaired IL-7 signaling.
This research proposal focuses on dissecting the structural, biophysical, and functional mechanisms of glycosaminoglycans and the common gamma-chain cytokine receptor in the IL-7 signaling pathway and the development of novel interleukin-7 variants to enhance or suppress this critical signaling pathway.
|Hong, Changwan; Luckey, Megan A; Ligons, Davinna L et al. (2014) Activated T cells secrete an alternatively spliced form of common Î³-chain that inhibits cytokine signaling and exacerbates inflammation. Immunity 40:910-23|
|LundstrÃ¶m, Wangko; Highfill, Steven; Walsh, Scott T R et al. (2013) Soluble IL7RÎ± potentiates IL-7 bioactivity and promotes autoimmunity. Proc Natl Acad Sci U S A 110:E1761-70|
|Garcia, Jacqueline; Sims, Kellie J; Schwacke, John H et al. (2011) Biochemical systems analysis of signaling pathways to understand fungal pathogenicity. Methods Mol Biol 734:173-200|
|Singh, Arpita; Qureshi, Asfia; Del Poeta, Maurizio (2011) Quantitation of cellular components in Cryptococcus neoformans for system biology analysis. Methods Mol Biol 734:317-33|
|McQuiston, Travis; Luberto, Chiara; Del Poeta, Maurizio (2010) Role of host sphingosine kinase 1 in the lung response against Cryptococcosis. Infect Immun 78:2342-52|